Ultrasound-guided triple-target “sandwich” technique for flare-ups of chronic Achilles tendinopathy: preliminary experience
Author Block: G. Reverchon, A. Bazzocchi, F. Ponti, G. Bilancia, D. Romeo, P. Spinnato; Bologna/IT
Purpose: Flare-ups of chronic Achilles tendinopathy (AT) represent a therapeutic challenge. Conservative options may fail, while surgery is often too invasive. We present our initial experience with a novel ultrasound-guided interventional procedure – the triple-target “sandwich” technique – designed to manage AT flare-ups in a minimally invasive manner.
Methods or Background: Between January and June, 7 procedures were performed on 5 patients with chronic AT flare-ups (2 women, 3 men; mean age 50 years). Under ultrasound guidance, with previous subcutanous and peritendinous tissue local anestesia, injections were performed at three levels: (1) intratendinous tissue with hyperosmolar glucose, (2) pre-Achilles bursa with anesthetic and triamcinolone, and (3) retro-Achilles bursa with anesthetic and water-soluble corticosteroid. Prolotherapy works by injecting an hyperosmolar glucose solution that mildly irritates the tissue, stimulating the body’s natural healing response. This helps the body produce new collagen, making the tendons stronger and reducing the pain.Patients were subsequently referred for rehabilitation. Pain scores (NRS) and range of motion (complete restoration, subtotal, partial and unchanged) were assessed at baseline, 1 week, 3 months, and 6 months.
Results or Findings: Mean pain scores significantly decreased from 8.8 at baseline to 1.5 at 1 week, 0.8 at 3 months, and 3.1 at 6 months (p=0.002). At 3-month follow-up, 42% of patients achieved complete recovery of motion, 42% subtotal recovery, and 14% partial recovery. At 6 months, complete recovery was maintained in 28%, subtotal in 28%, and partial in 42%. No complications or adverse events were reported.
Conclusion: The ultrasound-guided triple-target “sandwich” technique appears to be a safe, well-tolerated, and cost-effective procedure for the management of AT flare-ups. Despite the limitations of a small sample and short follow-up, these preliminary findings suggest promising clinical potential.
Limitations: Small patient cohort and limited follow-up.
Funding for this study: No funding was provided.
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: local IRB approval obtained.